Design, synthesis and biological evaluation of novel 4-arylaminopyrimidine derivatives possessing a hydrazone moiety as dual inhibitors of L1196M ALK and ROS1
Author:
Funder
Liaoning Excellent Talents in University
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference25 articles.
1. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology;Hallberg;Nat. Rev. Cancer,2013
2. Novel anaplastic lymphoma kinase inhibitors targeting clinically acquired resistance;Lu;J. Med. Chem.,2014
3. Global cancer statistics;Torre;CA Cancer J. Clin.,2015
4. ALK and ROS1 as a joint target for the treatment of lung cancer: a review;de la Bellacasa;Transl. Lung Cancer Res.,2013
5. EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors;Choi;N. Engl. J. Med.,2010
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis and Antiproliferative Properties of Some Spirocyclic Pyrimidine Hydrazones;ChemistrySelect;2024-02-21
2. Molecular hybrids integrated with imidazole and hydrazone structural motifs: Design, synthesis, biological evaluation, and molecular docking studies;Journal of Molecular Liquids;2023-12
3. Recent advances in the development of dual ALK/ROS1 inhibitors for non-small cell lung cancer therapy;European Journal of Medicinal Chemistry;2023-09
4. Synthesis, Biological Activity Evaluation and Molecular Docking of Imidazole Derivatives Possessing Hydrazone Moiety;Chemistry & Biodiversity;2023-05-23
5. Synthesis, cytotoxicity and DNA binding of novel Ni(II), Co(II) and Zn(II) complexes bearing pyrimidinyl hydrazone ligand;Journal of Molecular Structure;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3